-
- Research/Project Funding Opportunity
- Posted 11 months ago
Notice of Change: Extension of PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)" by one Council Round
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Change to Appendix Materials for PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Termination of PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Termination of PAR-21-057 "Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 3 years ago
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
at Department of Health and Human Services National Institutes of Health in United States